Ambio Life Sciences

Ambio Life Sciences was founded to set a new global standard for ibogaine treatment, where clinical excellence, cultural integrity, and transformative outcomes intersect. With more than 50 years of combined experience, our founders lead the field in safety protocols, research, and the delivery of innovative, human-centric care. Ambio operates world-class clinics dedicated to the treatment of addiction, traumatic brain injury, emotional trauma, chronic pain, and neurodegenerative conditions. We also support high-performance individuals, from special forces veterans to elite athletes seeking meaningful optimization. As the world’s leading integrative ibogaine provider, we help individuals create lasting, adaptive change in their lives. Ambio is advancing a new future of health: one rooted in science, shaped by experience, built to ignite agency and inspire living. People come to our treatment centers to receive treatments for drug detoxification, neuropathic pain, neurodegenerative disorders (Parkinson’s, MS, etc), traumatic brain injury, post-traumatic stress disorder, other mental health issues, as well as programs designed for healthy people looking to optimize their lifestyle and performance. Our treatments are integrated with cutting edge-medical technologies and we are part of several research programs focusing on the medical applications of the therapies that we provided. Our owners have a combined 35 years of experience in the field and maintain one of the largest and most comprehensive clinical ibogaine practices in the world.